COVID-19 rapid test Sofia 2

flufor nucleocapsid proteinsSARS-COV-2

The Sofia 2 Flu + SARS Antigen Fluorescent Immunoassay (FIA) uses advanced immunofluorescence-based lateral flow technology in a sandwich design for qualitative detection of nucleocapsid protein from influenza A and influenza B, and SARS-CoV-2. The Sofia 2 Flu + SARS Antigen FIA with the Sofia 2 analyzer provides automated and objective results in 15 minutes, allowing for testing of patients suspected of influenza A, influenza B, and COVID-19/2019-nCoV at the Point of Care. Healthcare professionals can purchase the Sofia 2 Flu + SARS Antigen FIA through select authorized distributors. One sample, three results Time savings, material conservation, and patient comfort. Features & Benefits Rapid results to support efficient dispositioning of patients. Objective, accurate results Reliable results without cross-reactivity to seasonal coronaviruses. Dual work modes Adjusts to your volume fluctuations. Allows for significant throughput and batching of samples in READ NOW Mode. Easy to use Seamless test workflow follows a similar format to CLIA-waived Sofia and Sofia 2 assays. Virena connection Provides automated tracking, data capture, government reporting, and exclusive disease mapping. Fluorescent technology with automated read Objective result that eliminates the subjectivity of a visual result. All necessary components included in kit Ready for use with Sofia 2 for nasal or nasopharyngeal swab procedure. Self-contained Test Cassette Clean, easy to use and dispose of. Sample type Direct: Nasal swab, nasopharyngeal swab Kit storage conditions Room temperature (15°C to 35°C / 59°F to 86°F)